Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2015 | Selecta Biosciences | $38.0M Series E | OrbiMed | 5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures, NanoDimension, Polaris Partners, The Column Group, AJU IB Investment, Flagship Ventures, NanoDimension, Osage University Partners, Polaris Partners, Ridgeback Capital Investments, Rusnano, Sanofi Ventures, Sphera Healthcare |
| Oct 15, 2014 | Selecta Biosciences | $20.0M Other Equity | — | Flagship Ventures, Handshake Ventures, I2BF Global Ventures, NanoDimension, OrbiMed, Polaris Partners, Rusnano |
| Oct 27, 2011 | BIND Therapeutics | $25.0M Other Equity | Anatoly Chubais | ARCH Venture Partners, DHK Investments, Endeavour Vision, Noubar Afeyan, NanoDimension, OrbiMed, Polaris Partners |
| Apr 1, 2010 | Selecta Biosciences | $15.0M Series C | OrbiMed | 5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures, NanoDimension, Polaris Partners, The Column Group, Flagship Ventures, NanoDimension, Polaris Partners |